首页> 外文期刊>Internal medicine. >Pulmonary Tuberculosis Complicated with Severe Thrombocytopenia with Diffuse Alveolar Hemorrhaging during Anti-tuberculosis Chemotherapy: An Autopsy Report
【24h】

Pulmonary Tuberculosis Complicated with Severe Thrombocytopenia with Diffuse Alveolar Hemorrhaging during Anti-tuberculosis Chemotherapy: An Autopsy Report

机译:抗结核化疗期间具有弥漫性肺泡出血的严重血小板减少的肺结核肺结核:尸检报告

获取原文
           

摘要

Tuberculosis may be accompanied by various hematological abnormalities during treatment, and occasionally thrombocytopenia is also noted. Most cases of thrombocytopenia in tuberculosis are moderate, and there are few reports about thrombocytopenia with diffuse alveolar hemorrhaging (DAH) in pulmonary tuberculosis. We describe the case of an 82-year-old man with pulmonary tuberculosis and tuberculous pleurisy. He underwent anti-tuberculosis chemotherapy; during tuberculosis treatment, he experienced DAH due to fulminant thrombocytopenia. Thrombocytopenia is a common finding in patients with pulmonary tuberculosis, but the laboratory findings should be carefully evaluated. Thrombocytopenia during anti-tuberculosis chemotherapy can cause life-threatening DAH.
机译:结核病可以伴有治疗过程中各种血液学异常,并且还注意到偶尔血小板减少症。结核病中大多数血小板减少症病例是中度的,血小板减少症患有肺结核(DAH)的血小板减少症少数报道。我们描述了一个82岁男子患有肺结核和结核性胸膜的案例。他接受了抗结核化疗;在结核病治疗过程中,他因暴风症血小板减少症而经历过DAH。血小板减少症是肺结核患者的常见发现,但应仔细评估实验室结果。抗结核化疗期间的血小板减少症会导致危及生命的DAH。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号